US 12,329,964 B2
Treatment paradigms for nerve stimulation
Bruce J. Simon, Santa Fe, NM (US); and Joseph P. Errico, Palm Beach Gardens, FL (US)
Assigned to ElectroCore, Inc., Rockaway, NJ (US)
Filed by ElectroCore, Inc., Rockaway, NJ (US)
Filed on Aug. 1, 2023, as Appl. No. 18/228,918.
Application 18/228,918 is a continuation of application No. 17/843,736, filed on Jun. 17, 2022, granted, now 11,779,756.
Application 17/843,736 is a continuation of application No. 17/402,690, filed on Aug. 16, 2021, granted, now 11,389,646, issued on Jul. 19, 2022.
Application 17/402,690 is a continuation of application No. 16/542,818, filed on Aug. 16, 2019, granted, now 11,191,953, issued on Dec. 7, 2021.
Application 16/542,818 is a continuation of application No. 13/952,916, filed on Jul. 29, 2013, granted, now 10,441,780, issued on Oct. 15, 2019.
Application 13/952,916 is a continuation in part of application No. 13/603,781, filed on Sep. 5, 2012, granted, now 8,983,628, issued on Mar. 17, 2015.
Application 13/603,781 is a continuation in part of application No. 13/222,087, filed on Aug. 31, 2011, granted, now 9,174,066, issued on Nov. 3, 2015.
Application 13/183,765 is a continuation in part of application No. 13/183,721, filed on Jul. 15, 2011, granted, now 8,676,324, issued on Mar. 18, 2014.
Application 13/222,087 is a continuation in part of application No. 13/183,765, filed on Jul. 15, 2011, granted, now 8,874,227, issued on Oct. 28, 2014.
Application 13/952,916 is a continuation in part of application No. 13/109,250, filed on May 17, 2011, granted, now 8,676,330, issued on Mar. 18, 2014.
Application 13/952,916 is a continuation in part of application No. 13/075,746, filed on Mar. 30, 2011, granted, now 8,874,205, issued on Oct. 28, 2014.
Application 13/952,916 is a continuation in part of application No. 13/005,005, filed on Jan. 12, 2011, granted, now 8,868,177, issued on Oct. 21, 2014.
Application 13/109,250 is a continuation in part of application No. 12/964,050, filed on Dec. 9, 2010, abandoned.
Application 13/952,916 is a continuation in part of application No. 12/859,568, filed on Aug. 19, 2010, granted, now 9,037,247, issued on May 19, 2015.
Claims priority of provisional application 61/488,208, filed on May 20, 2011.
Claims priority of provisional application 61/487,439, filed on May 18, 2011.
Claims priority of provisional application 61/471,405, filed on Apr. 4, 2011.
Claims priority of provisional application 61/451,259, filed on Mar. 10, 2011.
Claims priority of provisional application 61/415,469, filed on Nov. 19, 2010.
Prior Publication US 2023/0381499 A1, Nov. 30, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/00 (2006.01); A61N 1/04 (2006.01); A61N 1/05 (2006.01); A61N 2/00 (2006.01); A61B 5/00 (2006.01); A61B 5/369 (2021.01); A61N 2/02 (2006.01)
CPC A61N 1/0551 (2013.01) [A61N 1/00 (2013.01); A61N 1/0456 (2013.01); A61N 1/36014 (2013.01); A61N 1/36021 (2013.01); A61N 1/36025 (2013.01); A61N 2/006 (2013.01); A61B 5/369 (2021.01); A61B 5/4836 (2013.01); A61N 1/0408 (2013.01); A61N 1/36053 (2013.01); A61N 2/008 (2013.01); A61N 2/02 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A method of treating a symptom in a user, the method comprising:
positioning a contact surface of a device in contact with an outer skin surface of a neck of the user;
applying, via the device, an electrical impulse transcutaneously, via the contact surface, through the outer skin surface of the neck of the user to a nerve within the user according to a treatment paradigm; and
wherein the treatment paradigm is based at least in part on an application of the electrical impulse as a single dose from about 30 seconds to about 5 minutes and wherein the treatment paradigm comprises a treatment session during a day, wherein the treatment session comprises applying the single dose from 2 to 5 times during the day.